Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins
- 1 January 2008
- journal article
- Published by Taylor & Francis in The Physician and Sportsmedicine
- Vol. 36 (1) , 129-131
- https://doi.org/10.3810/psm.2008.12.22
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Enhanced HypeThe American Journal of Cardiology, 2008
- After ENHANCE: Is More LDL Cholesterol Lowering Even Better?Clinical Chemistry, 2008
- Simvastatin with or without Ezetimibe in Familial HypercholesterolemiaNew England Journal of Medicine, 2008
- Ezetimibe: cholesterol lowering and beyondExpert Review of Cardiovascular Therapy, 2008
- Effects of Torcetrapib in Patients at High Risk for Coronary EventsNew England Journal of Medicine, 2007
- Extended-release niacin/lovastatin: the first combination product for dyslipidemiaExpert Review of Cardiovascular Therapy, 2004